Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 Weeks
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
This study compared the effect of delayed-release metformin (Met DR) to placebo and extended
release metformin (Met XR) on glycemic control (fasting plasma glucose and HbA1c) and body
weight, and assessed the safety and tolerability of a range of doses of Met DR when
administered in subjects with type 2 diabetes mellitus (T2DM).